Abstract
Background Typhoid fever, caused by Salmonella enterica serovar Typhi and S. Paratyphi, remains a major public health issue in Nigeria, exacerbated by limited access to clean water, inadequate sanitation, and a lack of awareness about vaccination. To inform future interventions, this study investigates patients’ knowledge and perceptions of typhoid fever, including its diagnosis, treatment, and prevention.
Method A prospective cross-sectional study was conducted among adults attending EHA Clinics in Kano, Nigeria. A structured survey assessed participants’ knowledge of typhoid fever, its transmission, its symptoms, and their attitudes toward the typhoid vaccine. Data were analyzed using R software, with descriptive statistics and associations between variables examined.
Results Out of 443 participants, 71.4% were aware of typhoid fever, with 98% expressing confidence in its curability through appropriate treatment. Awareness of the typhoid vaccine, however, was low at 31.1%. Risk perception was high, with 75.5% of participants likely to trust a positive test result, and 63.4% believed they had a chance of contracting typhoid within the next year. Although antibiotics were widely regarded as beneficial (51.9%), misconceptions about vaccine harm persisted among some of the participants. Socio-demographic factors, particularly gender and education, were significantly associated with vaccine interest, with males and those with lower education levels showing greater interest in vaccination.
Conclusion Despite high awareness of typhoid fever, misconceptions and limited knowledge about the vaccine pose challenges for prevention in Nigeria. Targeted educational campaigns could address these gaps and promote better attitudes toward vaccination and preventive behaviors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was granted by the Kano State Ministry of Health Research Ethics Committee (approval number: NHREC/17/03//2018)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
nirmal.ravi{at}eha.ng, deborah.ayando{at}eha.ng
Data Availability
All data produced in the present work are contained in the manuscript
